Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats

Izumi Harukuni, Richard J. Traystman, Anish Bhardwaj, Raymond C. Koehler, Jeffrey R. Kirsch

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study sought to test the hypothesis that intravenous basic fibroblast growth factor (bFGF) inhibits the development of brain injury during transient focal ischemia. Halothane-anesthetized cats (n = 39) underwent left middle cerebral artery occlusion for 60 minutes. After the onset of reperfusion, wounds were closed and the cats were allowed to emerge from anesthesia. Experimental cats were treated with intravenous bFGF at a dose of either 2 or 5 μg/kg per hour, beginning 45 minutes after initiation of ischemia and continuing until 24 hours of reperfusion, when neurologic function and infarction volume were evaluated. The cats in the control group received diluent. Three of thirteen cats treated with bFGF 2 μg/kg/hour and six of sixteen cats treated with bFGF 5 μg/kg/hour died during the 24 hour reperfusion period. There was no difference in injury volume or neurologic evaluation score in the control group (n = 10; hemisphere injury, 1301 ± 306 mm3, mean±SE; score 53 ± 3), and cats treated with either 2 μg/kg/hour (n = 10; hemisphere injury, 1170 ± 292 mm3; score 50 ± 3) or 5 μg/kg/hour bFGF (n = 10; hemisphere injury, 1343 ± 374 mm3; score 50 ± 2). The data collected do not support the hypothesis that intravenous bFGF is neuroprotective in a cat model of transient focal ischemia.

Original languageEnglish (US)
Pages (from-to)160-165
Number of pages6
JournalJournal of Neurosurgical Anesthesiology
Volume10
Issue number3
StatePublished - Jul 1998
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 2
Brain Injuries
Cats
Ischemia
Wounds and Injuries
Reperfusion
Nervous System
Fibroblast Growth Factor 5
Fibroblast Growth Factor 10
Control Groups
Middle Cerebral Artery Infarction
Halothane
Infarction
Anesthesia

Keywords

  • Middle cerebral artery occlusion
  • Neuroprotection
  • Somatosensory evoked potential
  • Triphenyltetrazolium staining

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats. / Harukuni, Izumi; Traystman, Richard J.; Bhardwaj, Anish; Koehler, Raymond C.; Kirsch, Jeffrey R.

In: Journal of Neurosurgical Anesthesiology, Vol. 10, No. 3, 07.1998, p. 160-165.

Research output: Contribution to journalArticle

Harukuni, Izumi ; Traystman, Richard J. ; Bhardwaj, Anish ; Koehler, Raymond C. ; Kirsch, Jeffrey R. / Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats. In: Journal of Neurosurgical Anesthesiology. 1998 ; Vol. 10, No. 3. pp. 160-165.
@article{59b3f9be04844a6aa903dd3d0bca26ff,
title = "Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats",
abstract = "This study sought to test the hypothesis that intravenous basic fibroblast growth factor (bFGF) inhibits the development of brain injury during transient focal ischemia. Halothane-anesthetized cats (n = 39) underwent left middle cerebral artery occlusion for 60 minutes. After the onset of reperfusion, wounds were closed and the cats were allowed to emerge from anesthesia. Experimental cats were treated with intravenous bFGF at a dose of either 2 or 5 μg/kg per hour, beginning 45 minutes after initiation of ischemia and continuing until 24 hours of reperfusion, when neurologic function and infarction volume were evaluated. The cats in the control group received diluent. Three of thirteen cats treated with bFGF 2 μg/kg/hour and six of sixteen cats treated with bFGF 5 μg/kg/hour died during the 24 hour reperfusion period. There was no difference in injury volume or neurologic evaluation score in the control group (n = 10; hemisphere injury, 1301 ± 306 mm3, mean±SE; score 53 ± 3), and cats treated with either 2 μg/kg/hour (n = 10; hemisphere injury, 1170 ± 292 mm3; score 50 ± 3) or 5 μg/kg/hour bFGF (n = 10; hemisphere injury, 1343 ± 374 mm3; score 50 ± 2). The data collected do not support the hypothesis that intravenous bFGF is neuroprotective in a cat model of transient focal ischemia.",
keywords = "Middle cerebral artery occlusion, Neuroprotection, Somatosensory evoked potential, Triphenyltetrazolium staining",
author = "Izumi Harukuni and Traystman, {Richard J.} and Anish Bhardwaj and Koehler, {Raymond C.} and Kirsch, {Jeffrey R.}",
year = "1998",
month = "7",
language = "English (US)",
volume = "10",
pages = "160--165",
journal = "Journal of Neurosurgical Anesthesiology",
issn = "0898-4921",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats

AU - Harukuni, Izumi

AU - Traystman, Richard J.

AU - Bhardwaj, Anish

AU - Koehler, Raymond C.

AU - Kirsch, Jeffrey R.

PY - 1998/7

Y1 - 1998/7

N2 - This study sought to test the hypothesis that intravenous basic fibroblast growth factor (bFGF) inhibits the development of brain injury during transient focal ischemia. Halothane-anesthetized cats (n = 39) underwent left middle cerebral artery occlusion for 60 minutes. After the onset of reperfusion, wounds were closed and the cats were allowed to emerge from anesthesia. Experimental cats were treated with intravenous bFGF at a dose of either 2 or 5 μg/kg per hour, beginning 45 minutes after initiation of ischemia and continuing until 24 hours of reperfusion, when neurologic function and infarction volume were evaluated. The cats in the control group received diluent. Three of thirteen cats treated with bFGF 2 μg/kg/hour and six of sixteen cats treated with bFGF 5 μg/kg/hour died during the 24 hour reperfusion period. There was no difference in injury volume or neurologic evaluation score in the control group (n = 10; hemisphere injury, 1301 ± 306 mm3, mean±SE; score 53 ± 3), and cats treated with either 2 μg/kg/hour (n = 10; hemisphere injury, 1170 ± 292 mm3; score 50 ± 3) or 5 μg/kg/hour bFGF (n = 10; hemisphere injury, 1343 ± 374 mm3; score 50 ± 2). The data collected do not support the hypothesis that intravenous bFGF is neuroprotective in a cat model of transient focal ischemia.

AB - This study sought to test the hypothesis that intravenous basic fibroblast growth factor (bFGF) inhibits the development of brain injury during transient focal ischemia. Halothane-anesthetized cats (n = 39) underwent left middle cerebral artery occlusion for 60 minutes. After the onset of reperfusion, wounds were closed and the cats were allowed to emerge from anesthesia. Experimental cats were treated with intravenous bFGF at a dose of either 2 or 5 μg/kg per hour, beginning 45 minutes after initiation of ischemia and continuing until 24 hours of reperfusion, when neurologic function and infarction volume were evaluated. The cats in the control group received diluent. Three of thirteen cats treated with bFGF 2 μg/kg/hour and six of sixteen cats treated with bFGF 5 μg/kg/hour died during the 24 hour reperfusion period. There was no difference in injury volume or neurologic evaluation score in the control group (n = 10; hemisphere injury, 1301 ± 306 mm3, mean±SE; score 53 ± 3), and cats treated with either 2 μg/kg/hour (n = 10; hemisphere injury, 1170 ± 292 mm3; score 50 ± 3) or 5 μg/kg/hour bFGF (n = 10; hemisphere injury, 1343 ± 374 mm3; score 50 ± 2). The data collected do not support the hypothesis that intravenous bFGF is neuroprotective in a cat model of transient focal ischemia.

KW - Middle cerebral artery occlusion

KW - Neuroprotection

KW - Somatosensory evoked potential

KW - Triphenyltetrazolium staining

UR - http://www.scopus.com/inward/record.url?scp=0031846297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031846297&partnerID=8YFLogxK

M3 - Article

C2 - 9681404

AN - SCOPUS:0031846297

VL - 10

SP - 160

EP - 165

JO - Journal of Neurosurgical Anesthesiology

JF - Journal of Neurosurgical Anesthesiology

SN - 0898-4921

IS - 3

ER -